2018 Gastritis Drug Development – Pipeline Analysis – ResearchAndMarkets.com

The “2018
Gastritis (stomach inflammation) Drug Development- Pipeline Analysis
Report” report has been added to ResearchAndMarkets.com’s
offering.

The Gastritis market presents robust business growth opportunity.

Around 20 companies and universities are focusing on developing
treatment options for Gastritis.

To assist investigators and funding and regulatory organizations, the
publisher has come up with a comprehensive report on Gastritis pipeline.
The report provides insights into different therapeutic candidates in
preclinical, research, discovery, NDA/IND, pre registration, phase 1,
phase 2, and phase 3 trials). Drugs under development directly and
through combination with other drugs are also included.

Current status, developmental phase, participating companies and
entities, recent developments, orphan drug/ fast track/ other
designations, drug class are provided for each Gastritis pipeline
product. Mechanism of Action and the target area of the pipeline product
are also provided. Further, clinical and preclinical trials along with
results of the trials are also included in the report.

In addition to complete details of each product, the report provides key
trends in Gastritis pipeline studies. The products under development are
categorized according to their development phase, mechanism and company
to provide detailed insights into the type of drugs being developed and
the stages of development.

Key Topics Covered:

1 Gastritis (stomach inflammation) Pipeline Analysis

2 Gastritis (stomach inflammation) – Company Wise Pipeline Analysis

3 Gastritis (stomach inflammation) R&D Pipeline Snapshots

4 Recent Developments in Gastritis (stomach inflammation) Pipeline

5 Appendix

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/research/65bnq7/2018_gastritis?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005426/en/

Leave a Comment